These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32457835)

  • 1. Small Molecule Inhibitor C188-9 Synergistically Enhances the Demethylated Activity of Low-Dose 5-Aza-2'-Deoxycytidine Against Pancreatic Cancer.
    Kong R; Sun G; Li X; Wu L; Li L; Li Y; Wang F; Xuan P; Yang S; Sun B; Hu J
    Front Oncol; 2020; 10():612. PubMed ID: 32457835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decitabine and 5-azacitidine both alleviate LPS induced ARDS through anti-inflammatory/antioxidant activity and protection of glycocalyx and inhibition of MAPK pathways in mice.
    Huang X; Kong G; Li Y; Zhu W; Xu H; Zhang X; Li J; Wang L; Zhang Z; Wu Y; Liu X; Wang X
    Biomed Pharmacother; 2016 Dec; 84():447-453. PubMed ID: 27685787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
    Zuo S; Chen Y; Xu L; Tang Q; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
    Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss-of-function of DNA methyltransferase 1 by siRNA impairs the growth of non-small cell lung cancer with alleviated side effects via reactivation of RASSF1A and APC
    Lai Q; Xu YH; Chen Q; Tang L; Li AG; Zhang LF; Zhang CF; Song JF; Du ZZ
    Oncotarget; 2017 Aug; 8(35):59301-59311. PubMed ID: 28938637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-
    Xiang L; Dong W; Wang R; Wei J; Qiu G; Cen J; Chen Z; Zheng X; Hu S; Xie X; Cao X; Gu W
    Oncol Lett; 2014 Jul; 8(1):117-122. PubMed ID: 24959230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aza-2'-Deoxycytidine and CDDP Synergistically Induce Apoptosis in Renal Carcinoma Cells via Enhancing the APAF-1 Activity.
    Zhu X; Yi F; Chen P; Chen L; Zhang X; Cao C; Tan W
    Clin Lab; 2015; 61(12):1821-30. PubMed ID: 26882803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effect of DNA methylation inhibitor and histone deacetylase inhibitor on RASSF1A gene expression in U266 cells.].
    Lu F; Liu CF; Ma DX; Liu YP; Kong HL; Zhang JJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):223-7. PubMed ID: 20510036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
    Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
    Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon.
    Hong YD; Zhang J; Zhuang M; Li W; Wu PU; Li RT; Hu N; Bian BX; Song ZY; Wu FL
    Oncotarget; 2017 Dec; 8(70):114495-114505. PubMed ID: 29383097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitization of two human colon cancer cell lines to the antitumor effects of irinotecan combined with 5-aza-2'-deoxycytidine.
    Hakata S; Terashima J; Shimoyama Y; Okada K; Fujioka S; Ito E; Habano W; Ozawa S
    Oncol Lett; 2018 Apr; 15(4):4641-4648. PubMed ID: 29541236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aza-2'-Deoxycytidine enhances the radiosensitivity of breast cancer cells.
    Wang L; Zhang Y; Li R; Chen Y; Pan X; Li G; Dai F; Yang J
    Cancer Biother Radiopharm; 2013 Feb; 28(1):34-44. PubMed ID: 22917213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors.
    Morita S; Iida S; Kato K; Takagi Y; Uetake H; Sugihara K
    Oncology; 2006; 71(5-6):437-45. PubMed ID: 17690560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel.
    Shang D; Ito N; Kamoto T; Ogawa O
    Urology; 2007 May; 69(5):1007-12. PubMed ID: 17482960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2'-Deoxycytidine.
    Leadem BR; Kagiampakis I; Wilson C; Cheung TK; Arnott D; Trojer P; Classon M; Easwaran H; Baylin SB
    Cancer Res; 2018 Mar; 78(5):1127-1139. PubMed ID: 29282222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
    Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
    Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer.
    Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.